Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2016 1
2017 6
2018 4
2019 7
2020 6
2021 5
2022 1
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Fluorescence-guided assessment of bone and soft-tissue sarcomas for predicting the efficacy of telomerase-specific oncolytic adenovirus.
Uotani K, Tazawa H, Hasei J, Fujiwara T, Yoshida A, Yamakawa Y, Omori T, Sugiu K, Komatsubara T, Kondo H, Morita T, Kiyono M, Yokoo S, Hata T, Kunisada T, Takeda K, Urata Y, Fujiwara T, Ozaki T. Uotani K, et al. Among authors: hasei j. PLoS One. 2024 Feb 20;19(2):e0298292. doi: 10.1371/journal.pone.0298292. eCollection 2024. PLoS One. 2024. PMID: 38377118 Free PMC article.
Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression.
Sugiu K, Tazawa H, Hasei J, Yamakawa Y, Omori T, Komatsubara T, Mochizuki Y, Kondo H, Osaki S, Fujiwara T, Yoshida A, Kunisada T, Ueda K, Urata Y, Kagawa S, Ozaki T, Fujiwara T. Sugiu K, et al. Among authors: hasei j. Cancer Chemother Pharmacol. 2021 Sep;88(3):513-524. doi: 10.1007/s00280-021-04310-5. Epub 2021 Jun 10. Cancer Chemother Pharmacol. 2021. PMID: 34114067 Free article.
Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma.
Mochizuki Y, Tazawa H, Demiya K, Kure M, Kondo H, Komatsubara T, Sugiu K, Hasei J, Yoshida A, Kunisada T, Urata Y, Kagawa S, Ozaki T, Fujiwara T. Mochizuki Y, et al. Among authors: hasei j. Cancer Immunol Immunother. 2021 May;70(5):1405-1417. doi: 10.1007/s00262-020-02774-7. Epub 2020 Nov 5. Cancer Immunol Immunother. 2021. PMID: 33151368 Free PMC article.
30 results